Cariflex Pte. Ltd., a global player in synthetic rubber latex for medical applications, inaugurated its new $355 million production facility on Jurong Island, Singapore.
The plant, the largest of its kind worldwide, will significantly expand Cariflex’s manufacturing capacity to meet rising demand for high-quality latex used in surgical gloves, condoms, adhesives, and laminates.
The ceremony was officiated by Singapore’s Minister for Manpower and Second Minister for Trade and Industry Dr. Tan See Leng, alongside officials from South Korea and senior executives from Cariflex and parent company DL Chemical Co., Ltd.
Spanning 6.1 hectares, the facility strengthens Cariflex’s manufacturing network in Southeast Asia, a critical hub for medical product manufacturing.
Operations commenced in November 2024, with modular expansion capabilities designed to double the company’s 2023 production levels over time.
The investment aligns with Singapore’s push to develop high-value, innovation-driven industries. The new plant has created about 80 permanent jobs, with a focus on hiring and training local talent through programs conducted at Cariflex’s Brazil and Korea operations.
Cariflex, which relocated its global headquarters to Singapore in 2020, is the only company globally producing anionic catalyst-based synthetic rubber and latex, prized for its superior purity and softness.
Supported by Singapore’s Economic Development Board and JTC, the expansion positions Cariflex to better serve Southeast Asia’s growing demand while reinforcing its global market leadership.
Business News Asia